Literature DB >> 31207254

Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease.

Amy R Dunn1, Kristen M S O'Connell2, Catherine C Kaczorowski2.   

Abstract

Diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) arise from complex interactions of genetic and environmental factors, with genetic variants regulating individual responses to environmental exposures (i.e. gene-by-environment interactions). Identifying gene-by-environment interactions will be critical to fully understanding disease mechanisms and developing personalized therapeutics, though these interactions are still poorly understood and largely under-studied. Candidate gene approaches have shown that known disease risk variants often regulate response to environmental factors. However, recent improvements in exposome- and genome-wide association and interaction studies in humans and mice are enabling discovery of novel genetic variants and pathways that predict response to a variety of environmental factors. Here, we highlight recent approaches and ongoing developments in human and rodent studies to identify genetic modulators of environmental factors using AD and PD as exemplars. Identifying gene-by-environment interactions in disease will be critical to developing personalized intervention strategies and will pave the way for precision medicine.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Exposome; Gene-Environment; Genetic reference panel; Genome; Parkinson’s disease

Year:  2019        PMID: 31207254      PMCID: PMC6700747          DOI: 10.1016/j.neubiorev.2019.06.018

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  101 in total

1.  Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.

Authors:  Richard J Hodes; Neil Buckholtz
Journal:  Expert Opin Ther Targets       Date:  2016-02-07       Impact factor: 6.902

2.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

Authors:  Tiia Ngandu; Jenni Lehtisalo; Alina Solomon; Esko Levälahti; Satu Ahtiluoto; Riitta Antikainen; Lars Bäckman; Tuomo Hänninen; Antti Jula; Tiina Laatikainen; Jaana Lindström; Francesca Mangialasche; Teemu Paajanen; Satu Pajala; Markku Peltonen; Rainer Rauramaa; Anna Stigsdotter-Neely; Timo Strandberg; Jaakko Tuomilehto; Hilkka Soininen; Miia Kivipelto
Journal:  Lancet       Date:  2015-03-12       Impact factor: 79.321

3.  Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden.

Authors:  Miranka Wirth; Sylvia Villeneuve; Renaud La Joie; Shawn M Marks; William J Jagust
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

4.  Can education rescue genetic liability for cognitive decline?

Authors:  C Justin Cook; Jason M Fletcher
Journal:  Soc Sci Med       Date:  2014-07-07       Impact factor: 4.634

5.  n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood.

Authors:  Lawrence J Whalley; Ian J Deary; John M Starr; Klaus W Wahle; Kellie A Rance; Victoria J Bourne; Helen C Fox
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

6.  Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease.

Authors:  Ismaïl Ahmed; Pei-Chen Lee; Christina M Lill; Susan Searles Nielsen; Fanny Artaud; Lisa G Gallagher; Marie-Anne Loriot; Claire Mulot; Magali Nacfer; Tian Liu; Joanna M Biernacka; Sebastian Armasu; Kari Anderson; Federico M Farin; Christina Funch Lassen; Johnni Hansen; Jørgen H Olsen; Lars Bertram; Demetrius M Maraganore; Harvey Checkoway; Beate Ritz; Alexis Elbaz
Journal:  PLoS Genet       Date:  2014-11-20       Impact factor: 5.917

7.  Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.

Authors:  Anna K Engstrom; Jessica M Snyder; Nobuyo Maeda; Zhengui Xia
Journal:  Mol Neurodegener       Date:  2017-02-07       Impact factor: 14.195

8.  Mouse Phenome Database: an integrative database and analysis suite for curated empirical phenotype data from laboratory mice.

Authors:  Molly A Bogue; Stephen C Grubb; David O Walton; Vivek M Philip; Georgi Kolishovski; Tim Stearns; Matthew H Dunn; Daniel A Skelly; Beena Kadakkuzha; Gregg TeHennepe; Govindarajan Kunde-Ramamoorthy; Elissa J Chesler
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  Host genetic background influences diverse neurological responses to viral infection in mice.

Authors:  Candice L Brinkmeyer-Langford; Raquel Rech; Katia Amstalden; Kelli J Kochan; Andrew E Hillhouse; Colin Young; C Jane Welsh; David W Threadgill
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

10.  Association and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population.

Authors:  Eugene Lin; Shih-Jen Tsai; Po-Hsiu Kuo; Yu-Li Liu; Albert C Yang; Chung-Feng Kao
Journal:  Oncotarget       Date:  2017-04-11
View more
  32 in total

Review 1.  The Impact of Environmental Factors on 5-Hydroxymethylcytosine in the Brain.

Authors:  Joseph Kochmanski; Alison I Bernstein
Journal:  Curr Environ Health Rep       Date:  2020-06

Review 2.  Mouse Systems Genetics as a Prelude to Precision Medicine.

Authors:  Hao Li; Johan Auwerx
Journal:  Trends Genet       Date:  2020-02-06       Impact factor: 11.639

3.  Network-based analysis on genetic variants reveals the immunological mechanism underlying Alzheimer's disease.

Authors:  Pan Guo; Changying Cao; Yuequn Ma; Ju Wang
Journal:  J Neural Transm (Vienna)       Date:  2021-04-28       Impact factor: 3.575

4.  Life-long dietary restrictions have negligible or damaging effects on late-life cognitive performance: A key role for genetics in outcomes.

Authors:  Andrew R Ouellette; Niran Hadad; Andrew Deighan; Laura Robinson; Kristen O'Connell; Adam Freund; Gary A Churchill; Catherine C Kaczorowski
Journal:  Neurobiol Aging       Date:  2022-07-11       Impact factor: 5.133

Review 5.  Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Nat Rev Neurol       Date:  2022-09-30       Impact factor: 44.711

Review 6.  Translational approaches to understanding resilience to Alzheimer's disease.

Authors:  Sarah M Neuner; Maria Telpoukhovskaia; Vilas Menon; Kristen M S O'Connell; Timothy J Hohman; Catherine C Kaczorowski
Journal:  Trends Neurosci       Date:  2022-03-17       Impact factor: 16.978

7.  Systems Biology to Address Unmet Medical Needs in Neurological Disorders.

Authors:  Masha G Savelieff; Mohamed H Noureldein; Eva L Feldman
Journal:  Methods Mol Biol       Date:  2022

Review 8.  Approaching precision medicine by tailoring the microbiota.

Authors:  Gaeun Ryu; Hyojin Kim; Ara Koh
Journal:  Mamm Genome       Date:  2021-03-01       Impact factor: 2.957

9.  The Effects of Chronic Exposure to Ambient Traffic-Related Air Pollution on Alzheimer's Disease Phenotypes in Wildtype and Genetically Predisposed Male and Female Rats.

Authors:  Kelley T Patten; Anthony E Valenzuela; Christopher Wallis; Elizabeth L Berg; Jill L Silverman; Keith J Bein; Anthony S Wexler; Pamela J Lein
Journal:  Environ Health Perspect       Date:  2021-05-10       Impact factor: 9.031

Review 10.  Mouse Genetic Reference Populations: Cellular Platforms for Integrative Systems Genetics.

Authors:  Emily Swanzey; Callan O'Connor; Laura G Reinholdt
Journal:  Trends Genet       Date:  2020-09-30       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.